10 AstraZeneca legal leaders

From the General Counsel, who also holds the Chief Human Resources Officer and Chief Compliance Officer titles, through two deputy general counsel to seven assistant general counsel, all ten of these AstraZeneca legal leaders are in their roles today. Six have held IP, patent or IP litigation titles and three current titles name Oncology, Respiratory & Immunology or Cell Therapy, useful for seeing how legal support splits by therapy area, deal team and function.

10 professionals1 companyData retrieved October 13, 2026

Professionals to explore

  1. Adam McArthur

    LinkedIn

    Experience: Assistant General Counsel - Business Development and Technology · AstraZeneca

    $1,010 per 30-minute call

    Adam McArthur holds Assistant General Counsel - Business Development and Technology at AstraZeneca (since 2025) and was Chief Legal and Compliance Officer of Evinova, an AstraZeneca Healthtech Business (2023-2025). Adam's other AstraZeneca titles include Assistant General Counsel, Digital, IT and Operations (2016-2025), Assistant General Counsel - Operations (2014-2016) and Senior Counsel - Business Development (2007-2014).

    Is this you? Claim your profile and get paid for calls.

  2. Andrew Cook

    LinkedIn

    Experience: Assistant General Counsel, IP · AstraZeneca

    $1,010 per 30-minute call

    Andrew Cook, Assistant General Counsel, IP at AstraZeneca since 2018, is Global Head of the IP teams supporting the cardiovascular, renal and metabolism (CVRM), neuroscience and digital/AI therapy areas, with experience as a UK/European patent attorney and UK solicitor. Andrew was Senior Patent Attorney (2015-2018) and Patent Attorney (2010-2015) at AstraZeneca and held Team Leader, Drug Discovery (2010) and Project Leader Deputy Project Leader, Drug Discovery (2008-2010) there.

    Is this you? Claim your profile and get paid for calls.

  3. Dominic Hornblow

    LinkedIn

    Experience: Former Assistant General Counsel, Operations and EUCAN · AstraZeneca

    $1,010 per 30-minute call

    Dominic Hornblow became Assistant General Counsel, Operations and EUCAN at AstraZeneca in 2025, and held Legal Director (2019-2025) and Head of Legal and Procurement (2013-2022) there. A commercial lawyer by description, Dominic has worked on transactions and legal requirements such as IP licensing, data privacy and distribution agreements, and was an Associate at Jones Day (2001-2013).

    Is this you? Claim your profile and get paid for calls.

  4. Jeff Pott

    LinkedIn

    Experience: Chief Human Resources Officer, Chief Compliance Officer and General Counsel · AstraZeneca

    $4,039 per 30-minute call

    Jeff Pott has been General Counsel at AstraZeneca since 2009, leading the Legal and IP function, and took on Chief Human Resources Officer in 2021; the combined title Chief Human Resources Officer, Chief Compliance Officer and General Counsel dates from 2023. Jeff was Assistant General Counsel, Antitrust and IP Litigation (2004-2009) and Senior Litigation Counsel (1999-2003) there, a fit for questions on how the whole legal function is set up.

    Is this you? Claim your profile and get paid for calls.

  5. Kwame Mensah

    LinkedIn

    Experience: Assistant General Counsel, Cell Therapy · AstraZeneca

    $1,010 per 30-minute call

    Kwame Mensah holds two current AstraZeneca titles, Assistant General Counsel, Cell Therapy (since 2026) and Head of Legal, Cell Therapy (since 2024), providing lead legal and IP support for the Enterprise Cell Therapy Unit. Kwame was Assistant General Counsel, Oncology Biologics IP (2022-2026), Senior Director, Patents Immunooncology and Cell Therapy (2021-2022) and Patent Director, Immunooncology (2019-2021), a fit for cell therapy patent and legal questions.

    Is this you? Claim your profile and get paid for calls.

  6. Michelle Dennison Lutz

    LinkedIn

    Experience: Assistant General Counsel, Respiratory & Immunology · AstraZeneca

    $1,010 per 30-minute call

    Michelle Dennison Lutz is Assistant General Counsel, Respiratory & Immunology at AstraZeneca since 2020, serving as Global Legal Director for that therapy area. Michelle's other AstraZeneca titles are Legal Director, Cardiovascular, Renal & Metabolic Disease (2015-2020), Senior Counsel, Diabetes (2014-2015), Executive Director, Promotional Regulatory Affairs (2011-2014) and Senior Counsel (2006-2011), useful on therapy-area counsel and promotional regulatory questions.

    Is this you? Claim your profile and get paid for calls.

  7. Sebastian Kramer

    LinkedIn

    Experience: Assistant General Counsel, Global Employment Law · AstraZeneca

    $1,010 per 30-minute call

    Sebastian Kramer has been Assistant General Counsel, Global Employment Law at AstraZeneca since 2020, leading the global employment legal team and advising the HR Leadership Team and the Senior Executive Team (ExCo). Sebastian also held Legal Director - Global Employment (2019-2020), Senior Counsel - Global Employment (2015-2020) and Senior Counsel, Global Intellectual Property Litigation (2014) at AstraZeneca.

    Is this you? Claim your profile and get paid for calls.

  8. Shannon Carroll

    LinkedIn

    Experience: Former Deputy General Counsel, Oncology · AstraZeneca

    $1,683 per 30-minute call

    Since 2022 Shannon Carroll has been Deputy General Counsel, Oncology at AstraZeneca, after Assistant General Counsel, IP there (2016-2022). At MedImmune, Shannon was Senior Corporate Counsel (2014-2016), Corporate Counsel (2011-2014) and IP Counsel (2010-2011), so oncology legal support with an IP background is the natural topic.

    Is this you? Claim your profile and get paid for calls.

  9. Todd Spalding

    LinkedIn

    Experience: Senior Vice President, Deputy General Counsel · AstraZeneca

    $2,693 per 30-minute call

    Todd Spalding is Senior Vice President, Deputy General Counsel at AstraZeneca (since 2021). Todd has also been Senior Vice President and Head of Intellectual Property (2018-2021) and Vice President and Head of Intellectual Property (2013-2018) at Alexion Pharmaceuticals, Inc., and Assistant General Counsel (2009-2013) and Senior Counsel (2006-2009) at Bristol Myers Squibb, so Todd can speak to both a deputy GC seat and heading an IP function.

    Is this you? Claim your profile and get paid for calls.

  10. Yingji (Christopher) Chen

    LinkedIn

    Experience: Former Assistant General Counsel - Legal Lead for International Markets and Business Development · AstraZeneca

    $606 per 30-minute call

    Yingji (Christopher) Chen is Assistant General Counsel - Legal Lead for International Markets and Business Development at AstraZeneca, a role from 2025, following Director - BD Transactions (2023-2025). Christopher was also Legal Director (2021-2023) and Legal, Asso. Director (2020-2022) at AstraZeneca and Special Counsel at Covington & Burling LLP (2019-2020), a fit for business development transactions in international markets.

    Is this you? Claim your profile and get paid for calls.

Choose the right perspective

Jeff Pott and Todd Spalding fit questions about the legal function as a whole. Therapy-area counsel questions go to Shannon Carroll, Michelle Dennison Lutz or Kwame Mensah, patent and IP strategy to Andrew Cook or Kwame Mensah, business development deals to Adam McArthur or Yingji (Christopher) Chen, and employment or operations law to Sebastian Kramer or Dominic Hornblow.

Questions to take into the conversation

  1. 01How does a drugmaker decide when a therapy area gets its own deputy or assistant general counsel?
  2. 02How should patent counsel and business development lawyers divide work on an in-licensing deal for a new modality like cell therapy?
  3. 03What are the tradeoffs of combining the general counsel, chief compliance officer and HR leadership roles in one executive at a drugmaker?

About this directory

This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot; roles marked former had ended by then. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.

Other perspectives in Pharmaceuticals